ALETHEA CAPITAL MANAGEMENT, LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.

Quarter-by-quarter ownership
ALETHEA CAPITAL MANAGEMENT, LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,032,113
-2.9%
758,794
-0.2%
65.14%
+11.5%
Q2 2023$54,609,576
+12.7%
759,944
-3.3%
58.40%
+14.1%
Q1 2023$48,460,927
-20.0%
785,6830.0%51.17%
-11.9%
Q4 2022$60,599,730
+72.3%
785,683
-0.3%
58.10%
+30.7%
Q3 2022$35,172,000
+16.3%
788,263
-0.2%
44.43%
+17.3%
Q2 2022$30,250,000
-29.9%
789,813
-24.3%
37.87%
-3.0%
Q1 2022$43,176,000
+1.7%
1,043,159
-7.2%
39.06%
+8.4%
Q4 2021$42,462,000
+13.7%
1,123,929
-0.8%
36.04%
+9.6%
Q3 2021$37,332,000
-45.3%
1,132,645
+12.0%
32.86%
-23.4%
Q2 2021$68,198,000
+19.0%
1,010,945
-0.1%
42.91%
+22.7%
Q1 2021$57,311,000
-30.3%
1,012,203
+0.2%
34.96%
-15.2%
Q4 2020$82,268,000
+14.4%
1,009,799
+0.1%
41.24%
-15.2%
Q3 2020$71,901,000
-13.4%
1,009,131
+0.1%
48.66%
+0.3%
Q2 2020$82,980,000
+42.2%
1,008,508
+1.7%
48.53%
+28.4%
Q1 2020$58,345,000
-43.6%
991,754
-0.9%
37.79%
-14.8%
Q4 2019$103,420,000
+292.4%
1,000,580
-23.2%
44.36%
+165.8%
Q3 2019$26,359,000
-21.4%
1,302,3460.0%16.69%
-23.6%
Q2 2019$33,535,000
+106.6%
1,302,346
+14.2%
21.84%
+89.0%
Q1 2019$16,228,000
+533.4%
1,140,394
+25.5%
11.55%
+209.8%
Q4 2018$2,562,000
+35.6%
908,429
+65.9%
3.73%
+31.7%
Q3 2018$1,889,000
+117.9%
547,443
+102.1%
2.83%
+91.2%
Q2 2018$867,000
+204.2%
270,823
+132.5%
1.48%
+282.7%
Q1 2018$285,000
-56.3%
116,5000.0%0.39%
-62.7%
Q4 2017$652,000116,5001.04%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders